PureTech Health plc (PRTC)
NASDAQ: PRTC · Real-Time Price · USD
18.47
+0.12 (0.65%)
Feb 21, 2025, 4:00 PM EST - Market closed
PureTech Health Stock Forecast
Stock Price Forecast
The 1 analyst with a 12-month price forecast for PureTech Health stock has a target of 45, which predicts an increase of 143.64% from the current stock price of 18.47.
Analyst Consensus: Buy
* Price targets were last updated on Sep 9, 2024.
Analyst Ratings
According to 1 stock analyst, the rating for PureTech Health is "Buy". This means that the analyst believes this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Sep '24 | Oct '24 | Nov '24 | Dec '24 | Jan '25 | Feb '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1 | 1 | 1 | 1 | 1 | 1 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Leerink Partners | Leerink Partners | Buy Initiates $45 | Buy | Initiates | $45 | +143.64% | Sep 9, 2024 |
| Piper Sandler | Piper Sandler | Buy Maintains $37 → $44 | Buy | Maintains | $37 → $44 | +138.22% | Aug 25, 2022 |
| SVB Leerink | SVB Leerink | Buy Maintains $66 → $70 | Buy | Maintains | $66 → $70 | +278.99% | Aug 9, 2022 |
| SVB Leerink | SVB Leerink | Buy Maintains $70 → $66 | Buy | Maintains | $70 → $66 | +257.34% | Jun 15, 2022 |
| SVB Leerink | SVB Leerink | Buy Maintains $76 → $70 | Buy | Maintains | $76 → $70 | +278.99% | Jan 7, 2022 |
Financial Forecast
Revenue This Year
2.53M
from 3.33M
Decreased by -24.17%
Revenue Next Year
6.57M
from 2.53M
Increased by 160.00%
EPS This Year
-0.42
from -0.24
EPS Next Year
-0.56
from -0.42
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 5.3M | 13.7M | 29.4M | ||
| Avg | 2.5M | 6.6M | 14.1M | ||
| Low | n/a | n/a | n/a |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 57.7% | 440.6% | 347.8% | ||
| Avg | -24.2% | 160.0% | 115.4% | ||
| Low | - | - | - |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -0.44 | -0.58 | -0.65 | ||
| Avg | -0.42 | -0.56 | -0.63 | ||
| Low | -0.41 | -0.54 | -0.61 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.